We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+1.81%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.27B
AUM Growth
-$65.6M
Cap. Flow
-$59.3M
Cap. Flow %
-0.82%
Top 10 Hldgs %
12.57%
Holding
645
New
83
Increased
157
Reduced
287
Closed
69

Top Buys

Rank Stock Value
1
CPRI icon
Capri Holdings
CPRI
+$31.8M
2
AAP icon
Advance Auto Parts
AAP
+$29.8M
3
QDEL icon
QuidelOrtho
QDEL
+$25.3M
4
GLOB icon
Globant
GLOB
+$20.2M
5
FL
Foot Locker
FL
+$20M

Top Sells

Rank Stock Value
1
EQC
Equity Commonwealth
EQC
+$50.3M
2
RRX icon
Regal Rexnord
RRX
+$41.7M
3
SPXC icon
SPX Corp
SPXC
+$39.1M
4
KBR icon
KBR
KBR
+$24.6M
5
NVO
Novo Nordisk
NVO
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 18.35%
2 Industrials 17.9%
3 Financials 15.19%
4 Healthcare 13.59%
5 Consumer Discretionary 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COLL icon
501
Collegium Pharmaceutical
COLL
$1.15B
$1.12M 0.02%
38,983
-40,653
-51% -$1.35M
IP icon
502
International Paper
IP
$21.9B
$1.11M 0.02%
20,600
CORT icon
503
Corcept Therapeutics
CORT
$12.2B
$1.1M 0.02%
+21,784
New +$1.14M
OWL icon
504
Blue Owl Capital
OWL
$7.54B
$1.08M 0.01%
46,475
T icon
505
AT&T
T
$162B
$1.07M 0.01%
46,859
+50
+0.1% +$1.13K
MET icon
506
MetLife
MET
$62B
$1.07M 0.01%
13,025
NWN icon
507
Northwest Natural Holdings
NWN
$2.06B
$1.03M 0.01%
+26,046
New +$1.06M
TDS icon
508
Telephone and Data Systems
TDS
$3.92B
$1.03M 0.01%
+30,084
New +$915K
WEYS icon
509
Weyco Group
WEYS
$385M
$1.02M 0.01%
+27,240
New +$963K
AMPY icon
510
Amplify Energy
AMPY
$166M
$1.02M 0.01%
+170,317
New +$1.11M
VIPS icon
511
Vipshop
VIPS
$7.47B
$1.02M 0.01%
75,800
-20,200
-21% -$290K
ENB icon
512
Enbridge
ENB
$118B
$1.02M 0.01%
24,024
SB icon
513
Safe Bulkers
SB
$803M
$1.01M 0.01%
284,103
-1,625
-0.6% -$6.79K
PBR.A icon
514
Petrobras Class A
PBR.A
$109B
$1M 0.01%
84,700
MYGN icon
515
Myriad Genetics
MYGN
$285M
$989K 0.01%
72,117
+41,739
+137% +$770K
VALE icon
516
Vale
VALE
$62B
$965K 0.01%
108,774
MCS icon
517
Marcus Corp
MCS
$946M
$951K 0.01%
+44,227
New +$877K
CAG icon
518
Conagra Brands
CAG
$7.14B
$949K 0.01%
34,200
IFF icon
519
International Flavors & Fragrances
IFF
$20.6B
$929K 0.01%
10,985
SUPN icon
520
Supernus Pharmaceuticals
SUPN
$2.67B
$916K 0.01%
25,329
-48
-0.2% -$1.69K
HDB icon
521
HDFC Bank
HDB
$124B
$881K 0.01%
+27,600
New +$883K
FAST icon
522
Fastenal
FAST
$55.2B
$863K 0.01%
24,000
ACT icon
523
Enact Holdings
ACT
$6.68B
$857K 0.01%
26,462
+9,331
+54% +$323K
CATO icon
524
Cato Corp
CATO
$69.3M
$837K 0.01%
214,562
-1,058
-0.5% -$5.16K
IEFA icon
525
iShares Core MSCI EAFE ETF
IEFA
$191B
$831K 0.01%
11,820

Similar funds

Segall Bryant & Hamill's Q4 2024 Portfolio in Review

As of Q4 2024, Segall Bryant & Hamill held 645 positions worth $7.27B, down 0.9% from $7.33B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Segall Bryant & Hamill's Q4 2024 filing shows 83 new, 157 increased, 287 reduced and 69 closed positions. Its largest new stake was Capri Holdings: 1,168,893 shares worth $24.6M. The largest sale was Equity Commonwealth, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q4 2024 buy was Capri Holdings: 1,168,893 shares worth $24.6M.
  • Segall Bryant & Hamill added most to QuidelOrtho in Q4 2024, an estimated $25.3M increase.
  • Segall Bryant & Hamill's biggest Q4 2024 reduction was Regal Rexnord, cutting an estimated $41.7M.
  • Segall Bryant & Hamill fully exited Equity Commonwealth in Q4 2024, selling an estimated $50.3M.
  • Segall Bryant & Hamill's ten largest holdings make up 13% of its $7.27B portfolio in Q4 2024.
  • Segall Bryant & Hamill opened 83 new positions and closed 69 in Q4 2024.
  • Segall Bryant & Hamill's portfolio value fell 0.9% quarter-over-quarter to $7.27B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2024, filed 11 Feb 2025.